[Lilly’s GLP-1 Direct-To-Consumer Move, Changes The “Game Changer” Game](https://wbbsec.com/opinions-and-features/lillys-glp-1-direct-to-consumer-move-changes-the-game-changer-game/)
[Lilly’s GLP-1 Direct-To-Consumer Move, Changes The “Game Changer” Game](https://wbbsec.com/opinions-and-features/lillys-glp-1-direct-to-consumer-move-changes-the-game-changer-game/)
powered by bulletin
In: Opinions & Features

7.7.2023 | Forbes

By Steve Brozak

No greater buzzword exists than Artificial Intelligence (AI) to make a story headline flash. In healthcare, stories about AI being used to discover new drugs and faster, more accurate medical diagnoses are guaranteed clickbait. These goals may be the stuff of dreams, but make no mistake, AI is already here and it’s a moneymaker for the healthcare industry, and we need to understand how.

What Is AI?

First, it is important to define AI. Though a seemingly new addition to the lexicon, AI is not new. The discipline of combining computer science with robust datasets to facilitate problem solving began three quarters of a century ago. The earliest successful AI program was written in 1951 by Christopher Strachey, later director of the Programming Research Group at the University of Oxford. Today’s key to AI strength and success lies in access to robust datasets.

To read the entire article on Forbes, please click here…